3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Surgery
1
Stress, Psychological
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Seminoma
1
Recurrence
1
Rectal Neoplasms
1
Postoperative Complications
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Microsatellite Instability
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Intermittent Fasting
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
16
Cetuximab
13
Leucovorin
12
Fluorouracil
12
Bevacizumab
10
pembrolizumab
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
6
Irinotecan
6
Capecitabine
6
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
cemiplimab
3
Folfox protocol
3
Early Intervention, Educational
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
relatlimab
2
pertuzumab
2
palbociclib
2
fludarabine
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
adagrasib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Neoadjuvant Therapy
×
90 days
×
Clear all
No trials found.